ÌÇÐÄlogo’s reputation was built on a broad base of basic science research spanning all areas related to human health and disease. Addressing contemporary challenges in biomedical research and healthcare requires collaborative teams of scientists and clinicians from multiple disciplines. This has long been routine at ÌÇÐÄlogo. Find out more. Explore our:
Recent Discoveries
Revealing the unexpected structure of iron-exporter ferroportin.
Dr. Gido Van De Ven shares his experiences during postdoctoral training.
First case of Type 1 diabetes reversal using precision medicine.
CAR NKT cells, a promising step forward in the treatment of solid tumors.
NIH Funding
Reports by the Blue Ridge Institute for Medical Research of funding from the National Institutes of Health are one indicator of the depth and breadth of our research enterprise.
- More than $300 million – funding from the National Institutes of Health to ÌÇÐÄlogo, including subawards from other institutions for BCM FY25
- No. 23 – ÌÇÐÄlogo's rank among U.S. medical schools in direct NIH funding for federal FY25
No. 2 – ÌÇÐÄlogo's rank among Texas medical schools in direct NIH funding for federal FY25 (ÌÇÐÄlogo has ranked first in Texas since at least 1992)
Departments Ranked in the Top 30 in NIH Funding
#2 - Department of Molecular and Human Genetics
#2 - Department of Pediatrics
#8 - Department of Molecular and Cellular Biology
#8 - Department of Integrative Physiology
#8 - Department of Neurosurgery
#10 - Department of Neuroscience
#19 - Michael E. DeBakey Department of Surgery
#21 - Department of Ophthalmology
#21 - Department of Physical Medicine and Rehabilitation
#26 - Margaret M. and Albert B. Alkek Department of Medicine
#26 - Department of Biochemistry and Molecular Pharmacology
Faculty members are joined by special guests to demonstrate the importance of scientists and researchers talking with others about their work.